期刊文献+

思密达金双歧治疗新生儿母乳性黄疸临床探讨 被引量:1

Clinical discussion on treatment of the maternal milky jaundice of the newborn with Smecta Golden bifid
下载PDF
导出
摘要 目的探讨治疗新生儿母乳性黄疸的新方法。方法确诊后使用思密达1.5g与10%葡萄糖注射液10ml调匀喂服,8h1次;金双歧1片口服,8h1次。结果经治病儿均于用药后3d~4d皮肤黄染开始减退,7d~10d基本退尽。结论思密达、金双歧治疗新生儿母乳性黄疸疗效肯定,且无任何副作用。 Objective To investigate the new method of treating the maternal milky jaundice of the newborn. Methods The study was performed in the sick baby. Mix smecta 1.5g with 10%GS 10ml and feed it to the newborn, 8 hours per time. Golden bifid 1 tablet, 8 hours one time. Results 3-4 days later, the jaundice of the newborn begin to abate, and 7-10 days later, the jaundice disappeared completely. In addition, the level of uncombine bilirubin of serum decreased to the normal. Conclusion Smecta Golden bifid is effective affirm in treating the maternal milky jaundice of the newborn, and its therapeutic effect is definite and without side-effect.
作者 谢玉增 谢钊
出处 《基层医学论坛》 2007年第11期961-962,共2页 The Medical Forum
关键词 思密达 金双歧 新生儿 母乳性黄疸 Smecta Golden bifid Newborn Maternal milky jaundice
  • 相关文献

参考文献2

二级参考文献3

共引文献56

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部